PUBLISHER: The Business Research Company | PRODUCT CODE: 1693203
PUBLISHER: The Business Research Company | PRODUCT CODE: 1693203
Machine learning (ML) in the pharmaceutical industry market involves the application of artificial intelligence (AI) algorithms and techniques to enhance drug discovery, development, and manufacturing processes. Regulatory compliance and overcoming challenges related to data quality, research gaps, and regulatory uncertainty are essential for implementing ML solutions in this industry.
The primary components of machine learning in the pharmaceutical industry are solutions and services. Solutions are applications or systems that use ML algorithms to tackle specific challenges or tasks in the pharmaceutical sector. These solutions can be deployed on the cloud or on-premise and cater to enterprises of various sizes, including small and medium enterprises (SMEs) and large enterprises.
The machine learning (ML) in the pharmaceutical industry market research report is one of a series of new reports from The Business Research Company that provides machine learning (ML) in the pharmaceutical industry market statistics, including machine learning (ML) in the pharmaceutical industry global market size, regional shares, competitors with machine learning (ML) in the pharmaceutical industry market share, detailed machine learning (ML) in the pharmaceutical industry market segments, market trends, and opportunities, and any further data you may need to thrive in the machine learning (ML) in the pharmaceutical industry. This machine learning (ML) in the pharmaceutical industry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The machine learning (ML) in the pharmaceutical industry market size has grown exponentially in recent years. It will grow from $3.02 billion in 2024 to $4.11 billion in 2025 at a compound annual growth rate (CAGR) of 35.9%. The growth in the historic period can be attributed to increased adoption of federated learning, accelerated drug discovery timelines, enhanced drug safety and pharmacovigilance, expansion of precision medicine applications.
The machine learning (ML) in the pharmaceutical industry market size is expected to see exponential growth in the next few years. It will grow to $13.99 billion in 2029 at a compound annual growth rate (CAGR) of 35.8%. The growth in the forecast period can be attributed to increasing complexity of biological data, growing computational power, increasing industry awareness and education, patient-centric healthcare solutions. Major trends in the forecast period include AI-pharma partnerships and collaborations, drug-agnostic therapies, interoperability of ML systems, decentralized clinical trials, AI-driven biomarker discovery.
The growing use of artificial intelligence (AI) is fueling the expansion of machine learning (ML) in the pharmaceutical sector. AI, which mimics human cognition to execute intricate tasks such as analysis, reasoning, and learning, is a key driver behind ML, a subset of AI that employs algorithms trained on data to generate models capable of performing complex tasks. AI and ML have been harnessed in pharmaceutical technology and drug delivery design, providing accelerated solutions to intricate challenges. They hold the potential to revolutionize the drug delivery process, improve decision-making tools, and manage vast amounts of data for more effective decision-making. For example, as reported by Forbes in June 2023, around 432,000 UK organizations, or one in six, have adopted at least one AI technology. Furthermore, 68% of large businesses, 33% of medium-sized businesses, and 15% of small businesses have adopted at least one AI technology. Consequently, the increasing adoption of AI is poised to propel ML in the pharmaceutical industry.
Key players in the machine learning (ML) sector of the pharmaceutical industry are concentrating on creating user-friendly software platforms, including drug discovery software, to enhance their drug discovery capabilities. Drug discovery software encompasses various specialized tools and platforms utilized in identifying and developing new pharmaceutical drugs. For instance, in December 2023, Merck & Co. Inc., a US-based pharmaceutical company, introduced the AIDDISON drug discovery software. This software-as-a-service platform is the first of its kind, integrating drug discovery and synthesis through generative AI, ML, and computer-aided drug design. AIDDISON allows laboratories to pinpoint suitable drug candidates within a vast chemical space, virtually screen compounds from over 60 billion chemical targets, and assess synthesis routes for safer, more cost-effective, and higher-yield drug production.
In July 2023, BioNTech SE, a Germany-based biopharmaceutical company, acquired InstaDeep for $541 million. This acquisition is anticipated to enhance BioNTech's leading position in AI-powered drug discovery, design, and development. InstaDeep, a UK-based technology company, provides a variety of AI solutions and machine learning services tailored for the pharmaceutical sector.
Major companies operating in the machine learning (ML) in the pharmaceutical industry market report are Amazon.com Inc., Alphabet Inc., Microsoft Corporation, Dell Technologies Inc., Hitachi Ltd., International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Honeywell International Inc., Hewlett Packard Enterprise, NVIDIA Corporation, Thales SA, Atos SE, Hexagon AB, Palantir Technologies Inc., Verient Systems Inc., Alteryx Inc., Comet ML Inc., GAVS Technologies, NEC Corporation, Veritone Inc., H2O.ai Inc., Sparkcognition Inc., Akira AI, Deep Genomics Inc., Cloud Pharmaceuticals Inc., Atomwise Inc., Cyclica Inc., BioSymetrics Inc., Neptune Labs
North America was the largest region in the machine learning in the pharmaceutical industry market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the machine learning (ml) in the pharmaceutical industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the machine learning (ml) in the pharmaceutical industry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The machine learning (ML) in the pharmaceutical industry market consists of revenues earned by entities by providing components of machine learning (ML) in the pharmaceutical industry market such as solutions and services. The market value includes the value of related goods sold by the service provider or included within the service offering. The machine learning (ML) in the pharmaceutical industry market also includes sales of central processing units (CPUs), random access memory, storage systems, and graphics processing units (GPUs). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Machine Learning (ML) in The Pharmaceutical Industry Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on machine learning (ml) in the pharmaceutical industry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for machine learning (ml) in the pharmaceutical industry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The machine learning (ml) in the pharmaceutical industry market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.